Gushengtang Sets Out Board Line-Up and Key Committee Roles

Gushengtang Holdings Limited ( (HK:2273) ) has shared an update.

Gushengtang Holdings Limited has announced the current composition of its board of directors, led by executive director and chairman Tu Zhiliang, alongside non-executive directors Huang Jingsheng, Liu Kanghua and Cao Yanling, and independent non-executive directors Wang Lan, Zhong Weihe and Chang Xin. The company has also detailed the membership of its three key board committees—Audit, Remuneration and Nomination—clarifying leadership roles such as Wang Lan chairing the Audit Committee and Chang Xin chairing the Remuneration Committee, which underscores the group’s emphasis on corporate governance and oversight for its stakeholders.

These committee assignments formally delineate responsibilities for financial oversight, executive pay and board succession planning, which may enhance transparency and regulatory compliance for the Hong Kong–listed firm. The clarified governance structure can strengthen investor confidence by demonstrating a clear separation of duties between executive, non-executive and independent directors, particularly in areas critical to risk management and long-term strategic supervision.

The most recent analyst rating on (HK:2273) stock is a Sell with a HK$24.50 price target. To see the full list of analyst forecasts on Gushengtang Holdings Limited stock, see the HK:2273 Stock Forecast page.

More about Gushengtang Holdings Limited

Gushengtang Holdings Limited is a healthcare company listed in Hong Kong, focused on providing traditional Chinese medicine services and related healthcare offerings. The company operates under a board structure that includes executive, non-executive and independent non-executive directors, reflecting a typical governance framework for a listed healthcare operator.

Average Trading Volume: 1,411,005

Technical Sentiment Signal: Hold

Current Market Cap: HK$6.83B

See more data about 2273 stock on TipRanks’ Stock Analysis page.